Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease

Clinical trial NCT01155817 · COMPLETED

Trial details

NCT number: NCT01155817
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bone Marrow Transplant Failure Lymphoma, Non-Hodgkin Lymphoma, T-Cell, Peripheral

Start date: 2010-08-01
Primary completion: 2013-12-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.